A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal Cancer.
Autor: | Jeremy Chuang, Jun Gong, Sierra Min Li, Chongkai Wang, Fakih, Marwan, Chuang, Jeremy, Gong, Jun, Li, Sierra Min, Wang, Chongkai |
---|---|
Zdroj: | Clinical Colorectal Cancer; Sep2022, Vol. 21 Issue 3, p252-258, 7p |
Databáze: | Complementary Index |
Externí odkaz: |